Published: March 8th 2022 | Updated: September 20th 2024
Study: Removing Naïve T Cells is a Promising Strategy for Reducing GVHD
Published: August 11th 2022 | Updated: September 20th 2024
Biomarkers for Graft-Versus-Host Disease | Part 4
Published: August 11th 2022 | Updated: September 20th 2024
Biomarkers for Graft-Versus-Host Disease | Part 3
Published: August 10th 2022 | Updated: September 20th 2024
Biomarkers for Graft-Versus-Host Disease | Part 2
Published: August 10th 2022 | Updated: September 20th 2024
Biomarkers for Graft-Versus-Host Disease | Part 1
Published: September 13th 2024 | Updated: September 20th 2024
FDA Approves Subcutaneous Ocrevus for Multiple Sclerosis